Concepedia

Heinrich Griesemann

HG

Statistics

Publications

2

Citations

106

H-Index

2

Active since

2008

Affiliations

University of Tübingen(Current)

Heinrich Griesemann is an author at University of Tübingen specializing in oncology, immunotherapy, and hla class ii restriction.

Publications per year

2008–2011

2

Publications

2

Promiscuous survivin peptide induces robust CD4<sup>+</sup> T‐cell responses in the majority of vaccinated cancer patients

Melanie Widenmeyer, Heinrich Griesemann, Stefan Stevanović et al. · International Journal of Cancer · 2011 · 71 citations · Full text

, , +17

Human Melanoma Cytolysis by Combined Inhibition of Mammalian Target of Rapamycin and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2

Kerrington R. Molhoek, Heinrich Griesemann, Jianfen Shu et al. · Cancer Research · 2008 · 35 citations · Full text

, , +17

1–2 of 2